Corea L, Bentivoglio M, Provvidenza M
Int J Clin Pharmacol Res. 1984;4(1):35-40.
Systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), heart rate (HR) and tension time index (TTI) were evaluated in 20 uncomplicated hypertensives and in 20 normotensives at rest and during isometric exercise, performed by handgrip (HG). In the hypertensive population the same parameters were evaluated also after two and six weeks of treatment with a beta-blocking agent, nadolol, given in a single daily dose. In all cases isometric exercise induced a significant increase of SAP, DAP, MAP, HR and TTI and this increase was more relevant in hypertensives than in controls. In the hypertensive population, nadolol was effective in lowering arterial pressure at rest, and significantly reduced the levels of SAP, DAP, MAP, HR and TTI reached at the end of the HG test. Moreover, the increments of the investigated parameters induced by isometric exercise were significantly reduced after nadolol. The results suggest that nadolol, unlike other beta-blocking agents, exerts a "protective" action against the hazardous increments of blood pressure which may occur in the daily life of hypertensive subjects during involuntary isometric exercises, and which could trigger dangerous cardiovascular complications.
在20名单纯性高血压患者和20名血压正常者静息状态下及通过握力(HG)进行等长运动期间,评估了收缩压、舒张压和平均动脉压(SAP、DAP、MAP)、心率(HR)和张力时间指数(TTI)。在高血压人群中,在使用β受体阻滞剂纳多洛尔单一剂量每日治疗两周和六周后,也对相同参数进行了评估。在所有情况下,等长运动均导致SAP、DAP、MAP、HR和TTI显著升高,且这种升高在高血压患者中比在对照组中更明显。在高血压人群中,纳多洛尔可有效降低静息时的动脉血压,并显著降低HG试验结束时达到的SAP、DAP、MAP、HR和TTI水平。此外,纳多洛尔治疗后,等长运动引起的所研究参数的增量显著降低。结果表明,与其他β受体阻滞剂不同,纳多洛尔对高血压患者日常生活中在非自愿等长运动期间可能发生的、并可能引发危险心血管并发症的有害血压升高具有“保护”作用。